THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Singapore. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING, FORESEE PHARMACEUTICALS USA INC and HANGZHOU INNOGATE PHARMA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Singapore | 2 | |
#4 | United Kingdom | 1 | |
#5 | Mexico | 1 | |
#6 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Koolmeister Tobias | 10 |
#2 | Scobie Martin | 10 |
#3 | Helleday Thomas | 10 |
#4 | Jacques Sylvain | 10 |
#5 | Jacques-Cordonnier Marie-Caroline | 6 |
#6 | Desroses Matthieu | 6 |
#7 | Homan Evert | 5 |
#8 | Wallner Olov | 5 |
#9 | Henriksson Carl Martin | 5 |
#10 | Vallin Karl Sven Axel | 5 |
Publication | Filing date | Title |
---|---|---|
GB201712110D0 | New compounds and uses | |
EP3152195A1 | Mth1 inhibitors for treatment of cancer |